target directory

tbx 2400 is designed to enhance the engraftment of allogeneic hematopoietic stem cells by improving the ability of donor cells to produce blood and immune cells post transplant without modifying their genetic structure clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.